Search bioRxiv⌕ Search

bioRxiv · 10.1101/2022.05.19.492664

Deep Learning-Based Parameter Estimation for Neurophysiological Models of Neuroimaging Data

Abstract

AO_SCPLOWBSTRACTC_SCPLOWConnectome-based neural mass modelling is the emerging computational neuroscience paradigm for simulating large-scale network dynamics observed in whole-brain activity measurements such as fMRI, M/EEG, and related techniques. Estimating physiological parameters by fitting these models to empirical data is challenging however, due to large network sizes, often physiologically detailed fast-timescale system equations, and the need for long (e.g. tens of minutes) simulation runs. Here we introduce a novel approach to connectome-based neural mass model parameter estimation by employing optimization tools developed for deep learning. We cast the system of differential equations representing both neural and haemodynamic activity dynamics as a deep neural network, implemented within a widely used machine learning programming environment (PyTorch). This allows us to use robust industry-standard optimization algorithms, automatic differentiation for computation of gradients, and other useful functionality. The approach is demonstrated using a connectome-based network with nodal dynamics specified by the two-state RWW mean-field neural mass model equations, which we use here as a model of fMRI-measured activity and correlation fluctuations. Additional optimization constraints are explored and prove fruitful, including restricting the model to domains of parameter space near a bifurcation point that yield metastable dynamics. Using these techniques, we first show robust recovery of physiological model parameters in synthetic data and then, as a proof-of-principle, apply the framework to modelling of empirical resting-state fMRI data from the Human Connectome Project database. For resting state activity, the system can be understood as a deep net that receives uncorrelated noise on its input layer, which is transformed into network-wide modelled functional connectivity on its output layer. This is consistent with the prevailing conception in theoretical neuroscience of resting-state functional connectivity patterns as an emergent phenomenon that is driven by (effectively) random activity fluctuations, which are then in turn spatiotemporally filtered by anatomical connectivity and local neural dynamics.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Griffiths, J. D., Wang, Z., Ather, S. H., Momi, D., Rich, S. D., Diaconescu, A., McIntosh, A. R., Shen, K.. 2022-05-19. Deep Learning-Based Parameter Estimation for Neurophysiological Models of Neuroimaging Data. https://doi.org/10.1101/2022.05.19.492664

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience↗

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience↗

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience↗